PHSCN, A POTENT SYSTEMIC THERAPY FOR HUMAN BREAST CANCER THAT TARGETS ALPHA5 BETA1 INTEGRIN TO PREVENT METASTATIC INVASION

Regents Of The University Of Michigan

Investigators